New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

If everyone eligible had a lung cancer screening, 62,000 lives would be saved over five years, a new study shows.

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

Early detection of lung cancer can drastically improve survival rates. Sponsored by Virginia Mason Franciscan Health.

Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...

Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

The collaboration brings Qure.ai’s lung cancer detection and management tools to hospitals and health systems across the USA ...

A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade.

Gilead has reported that its phase 3 ASCENT-07 trial evaluating Trodelvy (sacituzumab govitecan-hziy) as a first-line ...

Qure.ai and Microsoft to deploy lung cancer AI on Precision Imaging Network, aiming to speed early detection and simplify ...

Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small ...